The ketogenic diet is not feasible as a therapy in a CD-1 nu/nu mouse model of renal cell carcinoma with features of Stauffer's syndrome

Silvia Vidali; Sepideh Aminzadeh-Gohari; René Feichtinger; Renaud Vatrinet; Andreas Koller; Felix Locker; Tricia Rutherford; Maura ODonnell; Andrea Stöger-Kleiber; Bridget Lambert; Thomas Felder; Wolfgang Sperl; Barbara Kofler

doi:10.18632/oncotarget.19306

The ketogenic diet is not feasible as a therapy in a CD-1 nu/nu mouse model of renal cell carcinoma with features of Stauffer's syndrome

Silvia Vidali (Erstautor/-in), Sepideh Aminzadeh-Gohari (Co-Autor/-in), René Feichtinger (Co-Autor/-in), Renaud Vatrinet, Andreas Koller (Co-Autor/-in), Felix Locker (Co-Autor/-in), Tricia Rutherford, Maura ODonnell, Andrea Stöger-Kleiber, Bridget Lambert, Thomas Felder (Co-Autor/-in), Wolfgang Sperl (Co-Autor/-in), Barbara Kofler^* (Letztautor/-in)

^*Korrespondierende/r Autor/-in für diese Arbeit

Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung

17 Quellenangaben (Web of Science)

Originalsprache	Englisch
Seiten (von - bis)	57201-57215
Fachzeitschrift	Oncotarget
Jahrgang	8
Ausgabenummer	34
DOIs	https://doi.org/10.18632/oncotarget.19306
Publikationsstatus	Veröffentlicht - 2017

Zugriff auf Dokument

10.18632/oncotarget.19306

Dieses zitieren

Vidali, S., Aminzadeh-Gohari, S., Feichtinger, R., Vatrinet, R., Koller, A., Locker, F., Rutherford, T., ODonnell, M., Stöger-Kleiber, A., Lambert, B., Felder, T., Sperl, W., & Kofler, B. (2017). The ketogenic diet is not feasible as a therapy in a CD-1 nu/nu mouse model of renal cell carcinoma with features of Stauffer's syndrome. Oncotarget, 8(34), 57201-57215. https://doi.org/10.18632/oncotarget.19306

@article{3b60b9d8712949faac00a405c7e50334,

title = "The ketogenic diet is not feasible as a therapy in a CD-1 nu/nu mouse model of renal cell carcinoma with features of Stauffer's syndrome",

keywords = "C-REACTIVE PROTEIN, MITOCHONDRIAL-DNA MUTATIONS, MEDIUM-CHAIN TRIGLYCERIDES, TUMOR-NECROSIS-FACTOR, HIGH-FAT DIET, ENERGY-METABOLISM, OXIDATIVE-PHOSPHORYLATION, CACHEXIA MODEL, CANCER-CELLS, WEIGHT-LOSS",

author = "Silvia Vidali and Sepideh Aminzadeh-Gohari and Ren{\'e} Feichtinger and Renaud Vatrinet and Andreas Koller and Felix Locker and Tricia Rutherford and Maura ODonnell and Andrea St{\"o}ger-Kleiber and Bridget Lambert and Thomas Felder and Wolfgang Sperl and Barbara Kofler",

note = "Vidali, Aminzadeh-Gohari, Feichtinger, Koller, Locker, Kofler: Paracelsus Med Univ, Dept Pediat, Res Program Receptor Biochem & Tumor Metab, Salzburg, Austria; Felder: Paracelsus Med Univ, Dept Lab Med, Salzburg, Austria; Sperl: Paracelsus Med Univ, Dept Pediat, Salzburg, Austria",

year = "2017",

doi = "10.18632/oncotarget.19306",

language = "English",

volume = "8",

pages = "57201--57215",

journal = "Oncotarget",

issn = "1949-2553",

number = "34",

}

Vidali, S, Aminzadeh-Gohari, S, Feichtinger, R, Vatrinet, R, Koller, A, Locker, F, Rutherford, T, ODonnell, M, Stöger-Kleiber, A, Lambert, B, Felder, T , Sperl, W & Kofler, B 2017, 'The ketogenic diet is not feasible as a therapy in a CD-1 nu/nu mouse model of renal cell carcinoma with features of Stauffer's syndrome', Oncotarget, Jg. 8, Nr. 34, S. 57201-57215. https://doi.org/10.18632/oncotarget.19306

The ketogenic diet is not feasible as a therapy in a CD-1 nu/nu mouse model of renal cell carcinoma with features of Stauffer's syndrome. / Vidali, Silvia (Erstautor/-in); Aminzadeh-Gohari, Sepideh (Co-Autor/-in); Feichtinger, René (Co-Autor/-in) et al.
in: Oncotarget, Jahrgang 8, Nr. 34, 2017, S. 57201-57215.

Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung

TY - JOUR

T1 - The ketogenic diet is not feasible as a therapy in a CD-1 nu/nu mouse model of renal cell carcinoma with features of Stauffer's syndrome

AU - Vidali, Silvia

AU - Aminzadeh-Gohari, Sepideh

AU - Feichtinger, René

AU - Vatrinet, Renaud

AU - Koller, Andreas

AU - Locker, Felix

AU - Rutherford, Tricia

AU - ODonnell, Maura

AU - Stöger-Kleiber, Andrea

AU - Lambert, Bridget

AU - Felder, Thomas

AU - Sperl, Wolfgang

AU - Kofler, Barbara

N1 - Vidali, Aminzadeh-Gohari, Feichtinger, Koller, Locker, Kofler: Paracelsus Med Univ, Dept Pediat, Res Program Receptor Biochem & Tumor Metab, Salzburg, Austria; Felder: Paracelsus Med Univ, Dept Lab Med, Salzburg, Austria; Sperl: Paracelsus Med Univ, Dept Pediat, Salzburg, Austria

PY - 2017

Y1 - 2017

KW - C-REACTIVE PROTEIN

KW - MITOCHONDRIAL-DNA MUTATIONS

KW - MEDIUM-CHAIN TRIGLYCERIDES

KW - TUMOR-NECROSIS-FACTOR

KW - HIGH-FAT DIET

KW - ENERGY-METABOLISM

KW - OXIDATIVE-PHOSPHORYLATION

KW - CACHEXIA MODEL

KW - CANCER-CELLS

KW - WEIGHT-LOSS

U2 - 10.18632/oncotarget.19306

DO - 10.18632/oncotarget.19306

M3 - Original Article

C2 - 28915665

SN - 1949-2553

VL - 8

SP - 57201

EP - 57215

JO - Oncotarget

JF - Oncotarget

IS - 34

ER -